Skip to main content
Top
Published in: Intensive Care Medicine 2/2019

01-02-2019 | What's New in Intensive Care

Infectious diseases: the 10 common truths I never believed

Authors: Jordi Rello, Emine Alp, Kalwaje Eshwara Vandana

Published in: Intensive Care Medicine | Issue 2/2019

Login to get access

Excerpt

The field of infectious diseases has caught us with many surprises. Even in the time of modern medicine, evolutionary perspectives on disease biology and management have continued to challenge us from time to time (Fig. 1). Integration of knowledge from various fields of science has opened an exciting arena, ruffling our beliefs learned in medical schools or during practice of clinical medicine. Ten selected topics that developed under the influence of certain evolutionary factors in medicine are presented in Table 1.
Table 1
Ten surprises in infectious diseases
 
Topics
1
Respiratory viruses are common causes of community-acquired pneumonia requiring hospitalization
2
MALDI-TOF significantly reduces the time to organism identification in blood
3
Carbapenenem-resistant Klebisella pneumoniae can be treated with carbapenems
4
Identification of drug response phenotypes helps to understand different responses in patients with sepsis
5
Weak evidence to support aerosolization of antimicrobials in respiratory infections
6
Oral cleansing with chlorhexidine may be harmful in intubated patients
7
Colistin is not the solution to treating MDR Gram-negative organisms
8
Therapeutic drug monitoring is required to optimize dosage in bacterial and fungal infections in mechanically ventilated patients
9
Invasive aspergillosis is a life-threating complication after viral pneumonia
10
Pulmonary manifestations are more common complications than bleeding when managing Ebola virus disease (EVD) outside of low- and middle income countries
Literature
3.
go back to reference Daikos GL, Markogiannakis A (2011) Carbapenemase-producing Klebsiella pneumoniae: (When) might we still consider treating with carbapenems? Clin Microbiol Infect 17:1135–1141CrossRefPubMed Daikos GL, Markogiannakis A (2011) Carbapenemase-producing Klebsiella pneumoniae: (When) might we still consider treating with carbapenems? Clin Microbiol Infect 17:1135–1141CrossRefPubMed
10.
go back to reference Alp E, Eren E, Elay G et al (2017) Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia. Infez Med 25:311–319PubMed Alp E, Eren E, Elay G et al (2017) Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia. Infez Med 25:311–319PubMed
12.
go back to reference Borgatta B, Gattarello S, Mazo CA et al (2017) The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs. Eur J Clin Microbiol Infect Dis 36:2155–2163. https://doi.org/10.1007/s10096-017-3039-z CrossRefPubMed Borgatta B, Gattarello S, Mazo CA et al (2017) The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs. Eur J Clin Microbiol Infect Dis 36:2155–2163. https://​doi.​org/​10.​1007/​s10096-017-3039-z CrossRefPubMed
Metadata
Title
Infectious diseases: the 10 common truths I never believed
Authors
Jordi Rello
Emine Alp
Kalwaje Eshwara Vandana
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 2/2019
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-018-5272-z

Other articles of this Issue 2/2019

Intensive Care Medicine 2/2019 Go to the issue

What's New in Intensive Care

Frugal innovation for critical care